Cargando…
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist, they come with challenges such as a heavy pill regimen, prolonged treatment duration, and a strict schedule, leading to mul...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609727/ https://www.ncbi.nlm.nih.gov/pubmed/37895831 http://dx.doi.org/10.3390/ph16101360 |